# Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept

> **NCT00384423** · PHASE2 · COMPLETED · sponsor: **Epix Pharmaceuticals, Inc.** · enrollment: 80 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** PRX-03140

## Key facts

- **NCT ID:** NCT00384423
- **Lead sponsor:** Epix Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-10
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384423, "Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00384423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*